Claims for Patent: 5,422,261

Summary for Patent: 5,422,261

Title:	Composition containing collagenase and chymopapain for hydrolyzing connective tissue to isolate cells
Abstract:	Proteolytic enzyme compositions and processes for digesting connective tissue are disclosed. The enzyme compositions include collagenase, which is essentially free of toxins and non-collagen specific components, and chymopapain, which is essentially free of toxins. The enzyme compositions are used for dissociating microvessel cells from connective tissue. Recovered microvessel cells are incorporated into artificial vessel grafts. The enzyme compositions preferably contain an aqueous mixture of collagenase having an activity of about 43 nkat/ml to about 51 nkat/ml, and chymopapain having an activity of about 0.22 nkat/ml to about 0.44 nkat/ml.
Inventor(s):	Lee; Catherine T. (Laguna Hills, CA), Hornacek; Cynthia (Trabuco cyn, CA), Dinh; Tan T. (Garden Grove, CA)
Assignee:	Baxter International Inc. (Deerfield, IL)
Application Number:	08/049,015
Patent Claims:	1. An enzyme composition useful for hydrolyzing connective tissue, said composition comprising: an aqueous mixture of collagenase having an activity of about 43 nkat/ml to about 51 nkat/ml, and chymopapain having an activity of about 0.22 nkat/ml to about 0.44 nkat/ml, in a physiologically compatible electrolyte solution buffered to a pH of about 7.0 to 7.4, wherein the activity of collagenase in nkat/ml is defined as the number of nanomoles of furylacryloyl Leu-Gly-Pro-Ala synthetic substrate (FALGPA) hydrolyzed per second by 1 ml of collagenase solution and the activity of chymopapain in nkat/ml is defined as the number of nanomoles of Benzoyl-L-arginine-p-nitroanilide synthetic substrate (BAPNA) hydrolyzed per second by 1 ml of chymopapain solution, said collagenase being essentially free of toxins and non-collagen active components and said chymopapain being essentially free of toxins. 2. The enzyme composition of claim 1 wherein said electrolyte solution is a phosphate buffered saline solution. 3. The enzyme composition of claim 1 wherein said electrolyte solution is an aqueous solution of sodium, potassium, magnesium, chloride, acetate, and gluconate ions buffered to a pH of 7.4, and having an osmolarity of 294 mOsmol/L. 4. The enzyme composition of claim 1 further comprising about 0.4 wt % human serum albumin.

Details for Patent 5,422,261

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Discure Medical, Llc	CHYMODIACTIN	chymopapain	For Injection	018663	11/10/1982		2039-03-29
Discure Medical, Llc	CHYMODIACTIN	chymopapain	For Injection	018663	08/21/1984		2039-03-29
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29